Zinc finger protein 343 (ZNF343) is a member of the zinc finger protein family, characterized by the presence of zinc finger domains that facilitate binding to DNA. Zinc finger domains are small protein structural motifs composed of approximately 30 amino acids that coordinate a zinc ion through a combination of cysteine and histidine residues. The coordination of the zinc ion provides structural integrity to the motif, allowing it to interact with DNA, RNA, or other proteins.As a transcription factor, ZNF343 utilizes these zinc finger motifs to bind specific DNA sequences, thereby regulating the transcription of target genes. The binding of transcription factors like ZNF343 to promoter regions of DNA can activate or repress the expression of genes, influencing a wide range of cellular functions such as growth, development, and response to environmental stimuli.
Although the specific biological roles and target genes of ZNF343 are not as extensively studied as some other zinc finger proteins, it is likely to be involved in crucial cellular processes. Typically, members of this protein family play roles in cell differentiation, cell cycle regulation, and the maintenance of cellular homeostasis. They may also partake in the repair of damaged DNA and the programmed cell death process known as apoptosis.ZNF343, like other zinc finger proteins, may have implications in human health and disease. Mutations or dysregulation of zinc finger proteins can lead to a variety of disorders, including developmental abnormalities and cancer. Understanding the exact functions of ZNF343 could provide insights into its role in these conditions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting gene expression patterns and indirectly influencing ZNF343 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase (HDAC) inhibitor, which may alter chromatin structure and gene expression, potentially impacting ZNF343. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Another HDAC inhibitor, potentially affecting gene regulation and indirectly influencing ZNF343 activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A DNA methyltransferase inhibitor, which can alter gene expression and potentially impact ZNF343. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to 5-Azacytidine, affects DNA methylation and gene expression, potentially influencing ZNF343. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A selective HDAC inhibitor, which may have implications for gene regulation involving ZNF343. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A BET bromodomain inhibitor, potentially influencing gene expression and regulatory mechanisms involving ZNF343. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
Another BET bromodomain inhibitor, which can affect transcription regulation, potentially impacting ZNF343. | ||||||
A-366 | 1527503-11-2 | sc-507495 | 10 mg | $195.00 | ||
A G9a/GLP histone methyltransferase inhibitor, potentially altering epigenetic marks and gene expression relevant to ZNF343. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
A selective EZH2/EZH1 inhibitor, potentially affecting gene expression patterns relevant to ZNF343. | ||||||